Cancer Treatment Protocols Expert

Key Expert – Cancer Treatment Protocols Expert (Cat. II) Project: Technical Assistance to the Syrian Ministry of Health – Strengthening Institutional Capacity and Governance.

Location:
Damascus, Syria Indicative Start Date: 9 December 2026 Implementation Period: 14 months (indicative end date: 9 February 2028) NTU International is currently identifying qualified experts for the EU-funded project “Technical Assistance to the Syrian Ministry of Health – Strengthening Institutional Capacity and Governance.” The assignment aims to support the institutional strengthening and governance capacities of the Syrian Ministry of Health, contributing to more effective institutional performance, evidence-based decision-making, accountability and sustainable capacity development. In this context, we are seeking a highly qualified Key Expert – Cancer Treatment Protocols Expert (Cat. II) to provide strategic and technical assistance in the development, harmonisation and implementation of evidence-based systemic anti-cancer therapy protocols, with particular emphasis on chemotherapy, medication safety, pharmacovigilance and clinical quality assurance. Qualifications and Skills Required
• Medical degree with board certification or equivalent specialisation in Clinical Oncology, Medical Oncology, Haematology-Oncology or Clinical Pharmacology.
• A Master's degree in Public Health or a related field is considered an asset.
• Strong capacity to harmonise cancer treatment practices across geographically dispersed and unevenly resourced oncology centres.
• Sound understanding of pharmaceutical supply-chain and quality-assurance considerations affecting essential cancer medicines.
• Ability to facilitate consensus-building among clinical stakeholders on standardised, evidence-based treatment pathways.
• Prior experience supporting ministries of health or national cancer-control programmes in post-conflict or early-recovery contexts is strongly preferred. General Professional Experience
• Minimum 10 years of clinical or technical experience in medical oncology, including substantial direct experience in the development, harmonisation or revision of national or institutional systemic anti-cancer therapy protocols, particularly chemotherapy protocols. Specific Professional Experience
• Demonstrated familiarity with current international treatment guidelines (e.g. WHO Essential Medicines List for cancer, NCCN, ESMO) and their contextual adaptation to resource-constrained or fragile health systems.
• Proven experience developing or strengthening pharmacovigilance and medication-safety systems specific to chemotherapy administration, including adverse-event reporting, dose-verification protocols and safe-handling procedures.
• Experience designing structured clinical training programmes for oncology teams (physicians, pharmacists and nursing staff) on protocol implementation, treatment sequencing and toxicity management.
• Experience developing monitoring and evaluation tools to track treatment adherence, clinical outcomes and protocol-related safety indicators across multiple oncology centres. Language Requirements
• English: Excellent written and spoken command – mandatory.
• Arabic: Working knowledge is considered a strong asset. If you are interested in this opportunity, please apply and upload your CV via LinkedIn or send to recruitment@ntu.eu. Please note that only selected candidates will be contacted due to the large amount of applicants.